MDV, Thanks for the reply. I have read a bit ab
Post# of 145407
![](/assets/46931549/no_avatar_available_thumb.jpg)
Thanks for the reply. I have read a bit about maraviroc and believed that Leronlimab as a competitive receptor site blocker is postulated to have a different effect that the non-competitive, allosteric modulating medications.
Of course I am parroting what I have read elsewhere.
What are your thoughts?
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)